Searchable abstracts of presentations at key conferences in endocrinology

ea0036P6 | (1) | BSPED2014

Comparing clinical practice with consensus guidelines for the investigation and management of British children with congenital adrenal hyperplasia

Knowles Rachel L , Zheng Sean , Oerton Juliet , Hindmarsh Peter , Kelnar Christopher , Dezateux Carol

Introduction: Congenital adrenal hyperplasia (CAH) is a rare condition affecting steroid-hormone synthesis. We reviewed the investigation and management of children with CAH against current international guidelines and explored variation by region and specialty of responsible clinician.Methods: Active national surveillance of new diagnoses of CAH in children under age 16 years and resident in Great Britain, undertaken prospectively from 2007 to 2009....

ea0035p1037 | Thyroid (non-cancer) | ECE2014

Grave's disease as an adverse effect of ipilimumab: first description of two cases

Coppin Mathilde , Arnault Jean-Philippe , Lameth Ileana De , Flahaut Helene , Desailloud Rachel

Ipilimumab is an immunomodulating agent for the treatment of metastatic melanoma. Ipilimumab is a human mAb which works by inhibiting cytotoxic T-lymphocyte antigen 4 (CTLA-4).CTLA4 typically works to down-regulate the T-cell response and protects self-antigens from recognition by the immune system. Since the T-cells are no longer down-regulated by this antigen, they are allowed to proliferate, thereby helping to prevent melanoma tumor evasion. As a resu...

ea0058p049 | Diabetes | BSPED2018

Use of diluted insulin in the management of very young children with type 1 diabetes: case report and literature review

Hendriks A Emile J , Ewen Ross L , Hoh Yoke Sin , Bhatti Nazia , Williams Rachel M , Thankamony Ajay

Introduction: The management of type 1 diabetes (T1D) in young children can be extremely challenging due to high insulin sensitivity, unpredictable eating and activity and difficulty recognizing symptoms of hypoglycaemia. Continuous subcutaneous insulin infusion (CSII) therapy is beneficial in managing young children, however the small insulin doses required challenge the accuracy of standard concentration (100 IU/ml) CSII.Case report and literature revi...

ea0034oc2.4 | Endocrine regulation of cell behaviour | SFEBES2014

Influence of glucocorticoid receptor density on development and remodeling of the heart

Richardson Rachel , Rog-Zielinska Eva , Thomson Adrian , Moran Carmel , Gray Gillian , Chapman Karen

Variation in the human glucocorticoid receptor (GR) gene associates with relative glucocorticoid resistance, hypertension and increased cardiovascular disease risk. Mice heterozygous for a null GR mutation (GR+/−) are also glucocorticoid resistant with raised circulating glucocorticoid levels and elevated blood pressure in adulthood. We have characterised the cardiac phenotype of these mice throughout development and investigated their response to cardiovascul...

ea0034oc6.1 | Clinical | SFEBES2014

Adverse outcome in glucocorticoid induced adrenal suppression; an analysis of short synacthen tests in 2782 patients

Chapman Matthew , Argese Nicola , Mani Dhanasekaran , Dabhi Vijay , Boot Christopher , Crowley Rachel , Stewart Paul , Tomlinson Jeremy

2–3% of the UK population are prescribed glucocorticoid (GC) therapy and their adverse effects contribute to a significant health burden. Suppression of endogenous GC secretion is a recognized complication of therapy, but the magnitude of the problem, together with its clinical consequences have not been determined. We conducted a retrospective study across all specialties in a large secondary–tertiary care center identifying 2782 patients who underwent 3666 250 &#95...

ea0034p145 | Clinical practice/governance and case reports | SFEBES2014

Training needs in adolescent health and transition in paediatric and adult trainees in diabetes and endocrinology in the UK

Gleeson Helena , Wright Rohana , Besser Rachel , Cheer Kelly , Dimitri Paul , Chapman Simon , on behalf of AYASIG

Background: Training is adolescent health and transition is lacking in medical education. Clinicians working in diabetes and endocrinology across paediatric and adult services need to have the skills to work effectively with this age group. Our aim was to identify the current state of training and to ascertain training needs in trainees.Methods: A questionnaire was developed based on existing questionnaires. Using trainee representatives all paediatric a...

ea0034p266 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Breaking NAD+: investigating NMRK2 as a regulator of muscle adaptation through NAD+ salvage

Doig Craig , Zielinska Agnieszka , Fletcher Rachel , McCabe Emma , Philp Andrew , Lavery Gareth

Exercise has undisputed health benefits mediated through metabolic adaptation in skeletal muscle. In contrast, a sedentary lifestyle, leads to impaired metabolic function and negative health outcomes such as insulin resistance and sarcopenia. Whilst exercise improves skeletal muscle metabolism, how the process is co-ordinated at a cellular level remains unclear. Recently, NAD+ has been suggested to play an important role in muscle adaptation, acting as a substrate f...

ea0034p272 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Liver fibrosis is common in Alstrom syndrome and can be identified using non-invasive tests

Hazlehurst Jonathan , Armstrong Matthew , Hodgkiss Jayne , Crowley Rachel , Geberhiwot Tarekegn , Newsome Phillip , Tomlinson Jeremy

Alstrom syndrome is an autosomal recessive ciliopathy that is characterised by increased body mass index, type 2 diabetes, retinal dystrophy, sensorineural hearing loss, cardiac fibrosis, and chronic kidney disease. Non-alcoholic fatty liver disease (NAFLD) in Alstrom patients ranges from simple steatosis, steatohepatitis and ultimately to fibrosis and cirrhosis. Nafld fibrosis score (http://nalfdscore.com/), enhanced liver fibrosis (ELF)-panel blood tests and Fibroscans are n...

ea0070ep71 | Bone and Calcium | ECE2020

Efficacy and safety of pamidronate in the treatment of parathyroid hormone-dependent hypercalcemia in hospitalized patients

Chava Rosenblum Rachel , Twito Orit , Barzilay-Yoseph Liat , Ramaty Erez , Klein Noa , Rotman-Pikielny Pnina

Background: Bisphosphonates are effective in malignancy-related hypercalcemia and have been beneficial in parathyroid-hormone (PTH)-dependent hypercalcemia in small randomized-controlled trials. However, data regarding efficacy and safety in PTH-dependent hypercalcemia is limited, and pamidronate is not indicated for this condition.Objective: To evaluate efficacy and safety of pamidronate in moderate-severe PTH-dependent hypercalcemia. Control groups wer...

ea0033oc1.4 | Oral Communications 1 | BSPED2013

Abnormal glucose homeostasis in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation is associated with reduced β-cell reserve and pancreatic volume

Wei Christina , Thyagiarajan Manigandan , Hunt Linda , Bradley Karin , Elson Ruth , Cox Rachel , Stevens Michael , Crowne Elizabeth

Background: Adult survivors of childhood acute lymphoblastic leukaemia (ALL) treated with bone marrow transplantation (BMT) and total body irradiation (TBI) have increased risk of impaired glucose tolerance (IGT) and diabetes mellitus (DM). Insulin resistance (IR) has been described, but effects of TBI on pancreatic growth and β-cell function have not been previously reported.Method: Two groups of childhood ALL survivors were studied: Group 1, treat...